Labetalol Injection Shortage

• • Labetalol injection, Baxter, 5 mg/mL, 4 mL vial, 10 count, NDC 36000-0320-10
  • Labetalol injection, Hikma, 5 mg/mL, 20 mL vial, 1 count, NDC 00143-9622-01
  • Labetalol injection, Hikma, 5 mg/mL, 40 mL vial, 1 count, NDC 00143-9623-01
  • Labetalol injection, Hikma, In 0.72% sodium chloride 100 mg/100 mL premixed bag, 10 count, NDC 00143-9363-10 - discontinued
  • Labetalol injection, Hikma, In 0.72% sodium chloride 200 mg/200 mL premixed bag, 10 count, NDC 00143-9364-10 - discontinued
  • Labetalol injection, Hikma, In 5% dextrose 200 mg/200 mL premixed bag, 10 count, NDC 00143-9366-10 - discontinued
  • Labetalol injection, Hikma, In 0.72% sodium chloride 300 mg/300 mL premixed bag, 10 count, NDC 00143-9365-10 - discontinued
  • Labetalol injection, Pfizer, 5 mg/mL, 4 mL Carpuject syringe, 10 count, NDC 00409-2339-34
  • Labetalol injection, Sagent, 5 mg/mL, 20 mL vial, 1 count, NDC 25021-0317-20
  • Labetalol injection, Sagent, 5 mg/mL, 40 mL vial, 1 count, NDC 25021-0317-40

• • Almaject has updated labetalol NDC numbers. The company has labetalol injection available.
  • Baxter has labetalol injection on shortage due to increased demand and third party supplier issues.
  • Fosun has labetalol injection available.
  • Hikma did not provide a reason for the shortage. Hikma discontinued the premixed bags in mid-2023.
  • Pfizer has labetalol injection on shortage due to increased demand and manufacturing delays.
  • Sagent did not provide a reason for the shortage.

• • Labetalol injection, Almaject, 5 mg/mL, 20 mL vial, 1 count, NDC 72611-0734-01
  • Labetalol injection, Almaject, 5 mg/mL, 40 mL vial, 1 count, NDC 72611-0738-01
  • Labetalol injection, Baxter, 5 mg/mL, 20 mL vial, 1 count, NDC 36000-0322-02
  • Labetalol injection, Baxter, 5 mg/mL, 40 mL vial, 1 count, NDC 36000-0324-02
  • Labetalol injection, Fosun Pharma, 5 mg/mL, 20 mL vial, 1 count, NDC 72266-0102-01
  • Labetalol injection, Fosun Pharma, 5 mg/mL, 40 mL vial, 1 count, NDC 72266-0103-01
  • Labetalol injection, Hikma, 5 mg/mL, 2 mL vial, 10 count, NDC 00641-6252-10
  • Labetalol injection, Pfizer, 5 mg/mL, 20 mL vial, 25 count, NDC 00409-0125-25
  • Labetalol injection, Pfizer, 5 mg/mL, 40 mL vial, 1 count, NDC 00409-2267-54

Estimated Resupply Dates

• • Baxter has labetalol 5 mg/mL 4 mL vials available in limited supply.
  • Hikma has labetalol 5 mg/mL 20 mL vials on back order and the company estimates a release date of late-November to early-December 2023. There are short-dated 5 mg/mL 40 mL vials available with expiration date of July 2024.
  • Pfizer has labetalol 5 mg/mL 4 mL Carpuject syringes available in limited supply.
  • Sagent has labetalol 5 mg/mL 20 mL vials on back order and the company estimates a release date of November 2023. There are short-dated 40 mL vials available with an expiration date of May 2024.